학술논문

CRISPR–Cas12-based detection of SARS-CoV-2
Document Type
article
Source
Nature Biotechnology. 38(7)
Subject
Vaccine Related
Pneumonia
Infectious Diseases
Biodefense
Lung
Clinical Research
Pneumonia & Influenza
Prevention
Emerging Infectious Diseases
Detection
screening and diagnosis
4.1 Discovery and preclinical testing of markers and technologies
Infection
Good Health and Well Being
Betacoronavirus
COVID-19
COVID-19 Testing
COVID-19 Vaccines
CRISPR-Cas Systems
Clinical Laboratory Techniques
Coronavirus Infections
Humans
Nucleic Acid Amplification Techniques
Pandemics
Pneumonia
Viral
RNA
Guide
Kinetoplastida
SARS-CoV-2
Time Factors
Language
Abstract
An outbreak of betacoronavirus severe acute respiratory syndrome (SARS)-CoV-2 began in Wuhan, China in December 2019. COVID-19, the disease associated with SARS-CoV-2 infection, rapidly spread to produce a global pandemic. We report development of a rapid (